Dr Michèle Masson-Trottier
Researcher biography
Dr Michèle Masson-Trottier is a certified speech-language pathologist and postdoctoral research fellow at the University of Queensland. Her work bridges speech-language therapy, neuroimaging, and open science to improve communication outcomes in individuals with post-stroke aphasia and neurodegenerative conditions such as primary progressive aphasia and Alzheimer's disease.
Her expertise includes:
-
Evidence-based language therapy development and adaptation
-
Therapy-induced neuroplasticity and functional neuroimaging (rs-fMRI, task-fMRI)
-
Technology-supported communication interventions
-
Culturally and linguistically responsive care models
-
Reproducible, containerised neuroimaging workflows for clinical populations
As part of the Neurodesk project, she leads the development of open, accessible neuroimaging tools tailored to clinical research needs, including lesion segmentation and cortical atrophy pipelines. Her work reduces technical barriers for clinician-researchers and promotes inclusive, translational science.
Her research is widely disseminated through peer-reviewed publications, international collaborations, and clinical knowledge translation. She is committed to making neuroscience tools and evidence-based interventions more usable and impactful across healthcare contexts.
Keywords: aphasia, neuroimaging, speech-language pathology, primary progressive aphasia, open science, therapy effectiveness, neuroplasticity, dementia, communication disorders, translational neuroscience